Coultreon Biopharma

Heverlee, Belgium

CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.

Apr 2026

Series A

Analytics Biopharma Biotechnology Health Care Life Science

Top Investors

Balyasny Asset ManagementNovo HoldingsSamsara BioCapitalLongwood FundSofinnova Investments

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Coultreon Biopharma

Who are Coultreon Biopharma's investors?

Coultreon Biopharma's investors include Balyasny Asset Management, Novo Holdings, Samsara BioCapital, Longwood Fund, Sofinnova Investments.

Where is Coultreon Biopharma headquartered?

Coultreon Biopharma is headquartered in Heverlee, Belgium.

What does Coultreon Biopharma do?

CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.

What stage is Coultreon Biopharma at?

Coultreon Biopharma is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 28, 2026.

MLA

"Coultreon Biopharma — Funding & Investors." VCBacked, April 28, 2026, https://www.vcbacked.co/company/coultreon-biopharma. Accessed June 3, 2026.

APA

VCBacked. (2026). Coultreon Biopharma — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/coultreon-biopharma

Wikipedia (cite web)

{{cite web |title=Coultreon Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/coultreon-biopharma |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 28, 2026.

Similar Companies in Analytics